$4.54
+0.09 (+2.02%)
Open$4.47
Previous Close$4.45
Day High$4.55
Day Low$4.31
52W High$5.73
52W Low$3.06
Volume—
Avg Volume191.0K
Market Cap92.36M
P/E Ratio—
EPS$-1.91
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+730.6% upside
Current
$4.54
$4.54
Target
$37.71
$37.71
$24.55
$37.71 avg
$48.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.69M | 23.13M | 22.16M |
| Net Income | 4.47M | 4.40M | 4.69M |
| Profit Margin | 18.9% | 19.1% | 21.2% |
| EBITDA | 8.95M | 8.70M | 7.31M |
| Free Cash Flow | 3.30M | 3.54M | 2.93M |
| Rev Growth | +11.0% | +7.8% | +15.1% |
| Debt/Equity | 0.08 | 0.09 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |